KLRG1 and neoplasm: As sE-cad has been reported to be a ligand for KLRG1 and we observed significant elevation of sE-cad levels in TIF and serum of WT tumors and mice, we then investigated the possibility that necroptosis engages KLRG1 to inhibit the anti-tumor activity of T cells.